Stay updated on CaboNivoIpi in Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the CaboNivoIpi in Thyroid Cancer Clinical Trial page.

Latest updates to the CaboNivoIpi in Thyroid Cancer Clinical Trial page
- Check3 days agoChange DetectedAdded new sites The University of Kansas Cancer Center - Olathe and Mercy Hospital Pittsburg, and added Diagnostic CAT Scan Service Type. Removed sites Olathe Health Cancer Center and Ascension Via Christi - Pittsburg from the locations list.SummaryDifference0.5%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdded a Results Posted section with primary and secondary outcomes (e.g., Objective Response Rate, TRAEs, DOR, PFS, OS) and exploratory biomarker/endpoints (Tumor Mutation Status, TILs, TCR repertoire, PD-1/PD-L1, PBMCs, MDSCs), plus results submission milestones and links to the Informed Consent Form and Study Protocol/Statistical Analysis Plan.SummaryDifference2%

- Check24 days agoChange DetectedThe screenshots show only minor formatting and layout adjustments with no changes to core study content (e.g., inclusion criteria, endpoints, enrollment, or locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check46 days agoChange DetectedUpdated page now shows a newer version (v3.2.0) with government operation status notices and “Results Submitted”; a specific resource (Differentiated thyroid carcinoma) and older revision (v3.1.0) were removed.SummaryDifference2%

- Check53 days agoChange DetectedSignificant expansion of immune biology terminology and a v3.1.0 revision, replacing v3.0.2; reflects an updated core content focus with broader terms.SummaryDifference0.5%

- Check67 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' link has been removed.SummaryDifference0.1%

Stay in the know with updates to CaboNivoIpi in Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CaboNivoIpi in Thyroid Cancer Clinical Trial page.